Dr Reddy's Laboratories Free Cash Flow 2010-2024 | RDY

Dr Reddy's Laboratories free cash flow for the twelve months ending September 30, 2024 was , a year-over-year.

  • Dr Reddy's Laboratories annual free cash flow for 2024 was $0.361B, a 37.65% decline from 2023.
  • Dr Reddy's Laboratories annual free cash flow for 2023 was $0.579B, a 218.13% increase from 2022.
  • Dr Reddy's Laboratories annual free cash flow for 2022 was $0.182B, a 48.88% decline from 2021.

Dr Reddy's Laboratories Free Cash Flow 2010-2024 | RDY

  • Dr Reddy's Laboratories annual free cash flow for 2024 was $0.361B, a 37.65% decline from 2023.
  • Dr Reddy's Laboratories annual free cash flow for 2023 was $0.579B, a 218.13% increase from 2022.
  • Dr Reddy's Laboratories annual free cash flow for 2022 was $0.182B, a 48.88% decline from 2021.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$19.4B
BridgeBio Pharma (BBIO)$4.4B
Bausch Health Cos (BHC)$2.9B
Amphastar Pharmaceuticals (AMPH)$2.2B
Supernus Pharmaceuticals (SUPN)$2B
Taysha Gene Therapies (TSHA)$506M
Personalis (PSNL)$245M
Assembly Biosciences (ASMB)$96M
Sol-Gel Technologies (SLGL)$15M
Evoke Pharma (EVOK)$6M
Teligent (TLGT)$0M